Outlook on the Global Prefilled Syringes Market (2020 to 2030) - Prefilled Syringes in Autoinjectors and Pen Injectors Presents Opportunities

DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Prefilled Syringes Market (5th Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

One of the key objectives of the report was to evaluate the current market size and the future opportunity within the prefilled syringes market. Based on various relevant parameters, such as the number of commercialized combination products, annual adoption rate, and expected pricing, the report provides an informed estimate of the likely evolution of the market over the period 2019-2030.

In order to provide a detailed future outlook, projections have been segmented on the basis of:

1. Therapeutic area (autoimmune disorders, infectious diseases, neurological disorders, blood disorders, oncological disorders, psychiatric disorders, respiratory disorders, cardiovascular disorders, metabolic disorders, ophthalmic diseases, orthopedic disorders and others)
2. Type of syringe
3. Type of material (glass and plastic)
4. Number of chambers (single chamber and dual chamber)
5. Type of drug molecule (antibodies, proteins, vaccines, small molecules, peptides, and others), and
6. Key geographies (North America, Europe (the UK, France, Italy, Spain, Germany and the rest of Europe), Latin America (Brazil, Mexico, Argentina and the rest of Latin America), Asia Pacific (Japan, China, India, South Korea and the rest of Asia Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and the rest of the Middle East))

In addition to other elements, the study includes:

• An overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.
• An overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes, featuring information on year of establishment, company size, geographical location of the developers, target therapeutic area, phases of development, type of drug molecule, route of administration, approval year (for marketed products), dosage details (for marketed products) and other approved dosage forms (for marketed products).
• A detailed competitiveness analysis of the various prefilled syringes that we came across, taking into consideration the supplier power (based on the employee size of developer/manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement/user-friendliness and other distinguishing features.
• A list of marketed drugs/therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future, shortlisted based on an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).
• An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development) based on different parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.
• An analysis of the various prefilled syringe combination product-related initiatives of big pharma players, based on parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and likely future adoption (based on potential injectable product candidates in the pipeline that are likely to be delivered via prefilled syringes), target therapeutic area(s) and type of drug molecule.
• A review of the landscape of contract fill/finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider.
• A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.
• An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries/geographical regions.
• Brief discussions of currently available specialty syringes, which include prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems.
• A case study on companies that are engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.
• Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
• Elaborate profiles of prominent prefilled syringe component manufacturers, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

Growth Drivers

• Rising Incidence of Chronic Diseases
• Growing Preference for Self-Injection
• Evolving Patient Demographics
• Growth of Biologics and Biosimilars Market
• Changing Pharmaceutical Strategies
• Increasing Focus on Prevention of Needlestick Injuries
• Prefilled Syringes in Autoinjectors and Pen Injectors

Companies Mentioned

• 3D Medicines
• Abbott
• AbbVie
• Abivax
• Ablynx
• Acceleron Pharma
• Accord Healthcare
• Activa Brand Products
• Adamis Pharmaceuticals
• Adimmune
• Adocia
• Advance Pharma Lab
• Aerpio Therapeutics
• Affibody
• Agenus
• Aguettant
• Aijex Pharma International
• Ajinomoto Bio-Pharma Services
• Akeso Biopharma
• AKRA DERMOJET
• Akums Drugs & Pharmaceuticals
• Al Biosciences
• Alder BioPharmaceuticals
• Alexion
• Alfa Corpuscles
• Alfasigma
• Alkermes
• Allergan
• Alnylam Pharmaceuticals
• Alphamab Jilin
• Altor BioScience
• Alvogen
• Alvotech
• Alzheimer's Association
• AMAG Pharmaceuticals
• Amega Biotech
• Amgen
• AMRI
• AnaptysBio
• Andes Biotechnologies
• Antares Pharma
• Antev
• Apellis Pharmaceuticals
• APL (Apotek Produktion & Laboratorier)
• Apobiologix
• Aptar Pharma
• Aquabiliti
• Araclon Biotech
• Archivel Farma
• Arecor
• Arrowhead Pharmaceuticals
• Arte
• Asarina Pharma
• Ascendis Pharma
• ASIT biotech
• Assistance Publique Hpitaux de Paris
• Astellas Pharma
• AstraZeneca
• AV7
• Axon Neuroscience
• B. Braun Medical
• Bavarian Nordic
• Baxalta
• Baxter
• Bayer
• Becton Dickinson
• Bespak
• Beximco Pharma
• Biocad
• Biocon
• Biocorp
• Biogen
• BioGenCell
• Bioinova
• BioLineRx
• BioMarin Pharmaceutical
• BioMimetix
• BioPharma Solutions (a business unit of Baxter)
• BioValve Technologies
• BirgiMefar
• Boehringer Ingelheim
• Bone Therapeutics
• Boryung Pharmaceutical
• Boston Biomedical
• Boston Pharmaceuticals
• Bracco Diagnostics
• Braeburn Pharmaceuticals
• Bristol-Myers Squibb
• Brooklyn ImmunoTherapeutics
• Caladrius Biosciences
• Camurus
• CARBOGEN AMCIS
• Cardinal Health
• Catalent
• Catalyst Biosciences
• CeleCor Therapeutics
• Celgene
• Celldex Therapeutics
• Celltrion
• Cenexi
• Centrexion Therapeutics
• CinnaGen
• Ciron Drugs
• Civi Biopharma
• Coherus Biosciences
• Consort Medical
• Corden Pharma
• Corvidia Therapeutics
• Covidien
• Credence Medsystems
• CrossJect
• CSL Behring
• CSPC ZhongQi Pharmaceutical Technology
• CytoDyn
• Daewoong Pharmaceutical
• Daiichi Sankyo
• DALI Medical Devices
• Datwlyer
• Delpharm
• DiaMedica Therapeutics
• Dicerna Pharmaceuticals
• Dr. Reddy's Laboratory
• Dynavax Technologies
• E3D
• Eisai
• Elcam Medical
• Eli Lilly
• Eloxx Pharmaceuticals
• Emcure Pharmaceuticals
• EMD Serono
• Emergent BioSolutions
• Enzon Pharma
• Ever Pharma
• Excelsior Medical
• Ferring Pharmaceuticals
• Follicum
• Foresee Pharmaceutical
• Fresenius Kabi
• Fujifilm Kyowa Kirin Biologics
• Future Injection Technologies
• Galapagos
• GC Pharma
• GE Healthcare
• Genentech
• Generon (Shanghai)
• Genexine
• Genocea Biosciences
• Genzyme
• GERCOR
• Gerresheimer
• Getz Pharma
• Gland Pharma
• GSK
• Guerbet
• HAL Allergy
• Hanmi Pharmaceutical
• Harbour BioMed
• Haselmeier
• Healthcare Pharmaceuticals
• Helixmith
• Hengrui Yuanzheng Bio-Technology
• Heron Therapeutics
• Hetero Drugs
• Hexal
• IDT Biologika
• Iltoo Pharma
• Il-Yang Pharmaceutical
• Immune Response BioPharma
• ImmunoVaccine
• Immunovant Sciences
• Immutep Australia
• Injecto
• Injex
• Inmune Bio
• Innovent Biologics
• Inovio Pharmaceuticals
• Intas Pharmaceuticals
• Intron Biotechnology
• Ionis Pharmaceuticals
• Ipsen
• ISU Abxis
• Italfarmaco
• Izana Bioscience
• J.O. Pharma
• Janssen
• Jiangsu Hansoh Pharmaceutical
• Jiangsu HengRui Medicine
• Jiangsu Hualan Pharmaceutical New Material
• Jiangsu T-Mab Biopharma
• Jiangxi Sanxin Medtec
• Jinan Youlyy Industrial
• Johnson & Johnson
• Kaleo Pharma
• Kang Stem Biotech
• Kemwell Biopharma
• KeyBioscience
• Kezar Life Sciences
• Kiniksa Pharmaceuticals
• Kyowa Hakko Kirin
• La Jolla Pharmaceutical
• Laboratorios SALVAT
• LEO Pharma
• LG Chem
• LIB Therapeutics
• Lonstroff
• Lonza
• Lundbeck
• Luye Pharma
• M3 Biotechnology
• Mada Medical Products
• Mallinckrodt
• Medefil
• Medicago
• MedicalChain International
• Medigen Vaccine Biologics
• MedImmune
• MedPro Safety Products
• Medtronic
• MedxL
• Merck
• Merck Serono
• Meridian
• Merit Medical
• Mika Medical
• Millendo Therapeutics
• Millennium Pharmaceuticals
• Minervax
• miRagen Therapeutics
• Mithra Pharmaceuticals
• Mitsubishi Tanabe
• Modus Therapeutics
• Mologen
• Mylan
• Nektar Therapeutics
• Nemera
• NeoImmuneTech
• Neumedicines
• Neuraly
• NGM Biopharmaceuticals
• Ningbo Zhengli Pharmaceutical Packing
• NIPRO
• Nora Therapeutics
• Nordic Bioscience
• NovaDigm Therapeutics
• Novartis
• Novavax
• Novo Nordisk
• NPS Pharmaceuticals (a subsidiary of Shire)
• Nuance Designs
• Nurse Assist
• OBI Pharma
• OliPass
• Olix Pharmaceuticals
• Ology Bioservices
• Omeros
• Ompi
• Oncobiologics
• Oncolix
• OncoPep
• OncoTherapy Science
• Oncovir
• OPKO Health
• Optimum Medical
• Orphan Disease Treatment Institute
• Osivax
• Otsuka Pharmaceutical
• Oval Medical Technologies
• Owen Mumford
• PA Consulting
• Palatin Technologies
• Patheon
• PCI Pharma Services
• PegBio
• PenJet
• Pfizer
• Pfizer CentreOne
• PharmaJet
• PhaseBio Pharmaceuticals
• PHC Injection Device Technologies
• Piramal Enterprises
• Pisa Farmaceutica
• Plas-Tech Engineering
• Pluristem Therapeutics
• Polaris Group
• PRA Health Sciences
• Primequal
• ProJect Pharmaceutics
• Promius Pharma
• Protagonist Therapeutics
• Proteo Biotech
• Qilu Pharmaceutical
• Qu Biologics
• Quratis
• Ra Pharmaceuticals
• Rafa Laboratories
• Raumedic
• Regenera Pharma
• Regeneron
• Reliance Life Sciences
• REMD Biotherapeutics
• Rentschler Biopharma
• Retractable Technologies
• Revolutions Medical
• RHEACELL
• Rhythm Pharmaceuticals
• Roche
• Roselabs biosciences
• Rovi Pharmaceutical
• R-Pharm
• Samsung Bioepis
• Samsung Biologics
• Sandoz
• Sanofi
• SCHERDEL Medtec
• Schering Medipharm
• Schott
• Schott-Kaisha
• Seqirus
• Serina Therapeutics
• Shandong Pharmaceutical Glass
• Shandong Weigao
• Shandong Zibo Minkang Pharmaceutical Packing
• Shanghai Biomabs Pharmaceutical
• Shenyang Sunshine Pharmaceutical
• Shin Yan Sheno Precision Industrial
• Shire
• SHL Group
• Siegfried Holding
• Sinocelltech
• SiO2 Medical Products
• Smiths Medical
• Swedish Orphan Biovitrum (SOBI)
• Spectrum Pharmaceuticals
• Splash Pharmaceuticals
• Square Pharmaceuticals
• SRI International
• Stealth BioTherapeutics
• Sun BioPharma
• Sun Pharma
• Suzuken
• SynDevRx
• Synermore Biologics
• Taisei Kako
• Takeda
• Terumo Europe
• Teva Pharmaceutical
• The Medical House
• The Medicines Company
• The National Medical Products
• Themis Bioscience
• Therachon
• TikoMed
• Tip-Top
• Tolmar
• Transcoject
• Transgene
• Troikaa
• Turnstone Biologics
• Tyfill Pharmapack
• UCB Biopharma
• Union Medico
• United Neuroscience
• US Medical Instruments
• Vaccibody
• Vaccitech
• Valeant Pharmaceutical
• Valeritas
• Valneva
• Vaxine
• Vetter Pharma
• Viela Bio
• ViiV Healthcare
• Vir Biotechnology
• Viriom
• Vitaeris
• VLP Therapeutics
• West Pharmaceutical
• Xbiotech
• XEME Biopharma
• YangZhong Wealth Metal
• YL Biologics
• Ypsomed
• Zealand Pharma
• Zhejiang Huahai Pharmaceutical
• Zogenix
• ZymoGenetics

For more information about this report visit https://www.researchandmarkets.com/r/46ep1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com